The link between insulin resistance parameters and serum uric acid is mediated by adiposity

Atherosclerosis

Volumn 270, Issue , 2018, Pages 180-186

  Mazidi, Mohsen ^a,b   Katsiki, Niki ^c   Mikhailidis, Dimitri P ^d   Banach, Maciej ^e,f,g  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b International College   (China)

^c ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e MEDICAL UNIVERSITY OF LODZ   (Poland)

^f POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^g UNIVERSITY OF ZIELONA GÓRA   (Poland)

Author keywords

Adiposity; Glucose homeostasis; Inflammation; Insulin resistance; Serum uric acid

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLUCOSE; TRIACYLGLYCEROL; URIC ACID; AUTACOID; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; CROSS-SECTIONAL STUDY; HOMEOSTASIS; HYPERURICEMIA; METABOLISM; NUTRITION; PATHOPHYSIOLOGY;

ADIPOSITY; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GLYCATED HEMOGLOBIN A; HOMEOSTASIS; HUMANS; HYPERURICEMIA; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; NUTRITION SURVEYS; UNITED STATES; URIC ACID; WAIST CIRCUMFERENCE;

EID: 85042075265     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2017.12.033     Document Type: Article

References (63)

1. Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 350:14 (2004), 1387–1397.
2. Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321:7255 (2000), 199–204 Clinical research ed.
3. Kang, D.H., Park, S.K., Lee, I.K., Johnson, R.J., Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J. Am. Soc. Nephrol.: JASN 16:12 (2005), 3553–3562.
4. Puig, J.G., Martinez, M.A., Hyperuricemia, gout and the metabolic syndrome. Curr. Opin. Rheumatol. 20:2 (2008), 187–191.
5. Katsiki, N., Doumas, M., Athyros, V.G., Karagiannis, A., Hyperuricemia as a risk factor for cardiovascular disease. Expet Rev. Cardiovasc. Ther. 13:1 (2015), 19–20.
6. Katsiki, N., Karagiannis, A., Athyros, V.G., Mikhailidis, D.P., Hyperuricaemia: more than just a cause of gout?. J. Cardiovasc. Med. 14:6 (2013), 397–402.
7. Katsiki, N., Papanas, N., Fonseca, V.A., Maltezos, E., Mikhailidis, D.P., Uric acid and diabetes: is there a link?. Curr. Pharmaceut. Des. 19:27 (2013), 4930–4937.
8. Borghi, C., Cicero, A.F.G., Serum uric acid and cardiometabolic disease: another brick in the Wall?. Hypertension 69:6 (2017), 1011–1013 (Dallas, Tex: 1979).
9. Cicero, A.F., Rosticci, M., Bove, M., Fogacci, F., Giovannini, M., Urso, R., et al. Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study. Ann. Med. 49:4 (2017), 275–282.
10. Frohlich, M., Imhof, A., Berg, G., Hutchinson, W.L., Pepys, M.B., Boeing, H., et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23:12 (2000), 1835–1839.
11. Ruggiero, C., Cherubini, A., Ble, A., Bos, A.J., Maggio, M., Dixit, V.D., et al. Uric acid and inflammatory markers. Eur. Heart J. 27:10 (2006), 1174–1181.
12. Hairong, N., Zengchang, P., Shaojie, W., Weiguo, G., Lei, Z., Jie, R., et al. Serum uric acid, plasma glucose and diabetes. Diabetes Vasc. Dis. Res. 7:1 (2010), 40–46.
13. Meisinger, C., Doring, A., Stockl, D., Thorand, B., Kowall, B., Rathmann, W., Uric acid is more strongly associated with impaired glucose regulation in women than in men from the general population: the KORA F4-Study. PLoS One, 7(5), 2012, e37180.
14. Oda, E., Kawai, R., Sukumaran, V., Watanabe, K., Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern. Med. 48:20 (2009), 1785–1791 (Tokyo, Japan).
15. Herman, J.B., Goldbourt, U., Uric acid and diabetes: observations in a population study. Lancet 2:8292 (1982), 240–243.
16. Cicero, A.F., Derosa, G., Rosticci, M., D'Addato, S., Agnoletti, D., Borghi, C., Long-term predictors of impaired fasting glucose and type 2 diabetes in subjects with family history of type 2 diabetes: a 12-years follow-up of the Brisighella Heart Study historical cohort. Diabetes Res. Clin. Pract. 104:1 (2014), 183–188.
17. Jia, Z., Zhang, X., Kang, S., Wu, Y., Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: a meta-analysis of cohort studies. Diabetes Res. Clin. Pract. 101:1 (2013), 88–96.
18. Krishnan, E., Pandya, B.J., Chung, L., Hariri, A., Dabbous, O., Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am. J. Epidemiol. 176:2 (2012), 108–116.
19. Juraschek, S.P., McAdams-Demarco, M., Miller, E.R., Gelber, A.C., Maynard, J.W., Pankow, J.S., et al. Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. Am. J. Epidemiol. 179:6 (2014), 684–691.
20. Tsushima, Y., Nishizawa, H., Tochino, Y., Nakatsuji, H., Sekimoto, R., Nagao, H., et al. Uric acid secretion from adipose tissue and its increase in obesity. J. Biol. Chem. 288:38 (2013), 27138–27149.
21. Richiardi, L., Bellocco, R., Zugna, D., Mediation analysis in epidemiology: methods, interpretation and bias. Int. J. Epidemiol. 42:5 (2013), 1511–1519.
22. Robins, J.M., Greenland, S., Identifiability and exchangeability for direct and indirect effects. Epidemiology 3:2 (1992), 143–155.
23. Mazidi, M., Wong, N.D., Katsiki, N., Mikhailidis, D.P., Banach, M., Dietary patterns, plasma vitamins and Trans fatty acids are associated with peripheral artery disease. Lipids Health Dis., 16(1), 2017 Dec 28, 254, 10.1186/s12944-017-0635-y.
24. Mazidi, M., Cicero, A.F., Kengne, A.P., Banach, M., Association Between Plasma Trans-Fatty Acid Concentrations and Measures of Glucose Homeostasis and Cardiovascular Risk Factors in Adults in NHANES 1999-2000. Angiology, 2017 Jan 1, 3319717745987, 10.1177/0003319717745987 [Epub ahead of print] PMID: 29241351.
25. Mazidi, M., Shivappa, N., Wirth, M.D., Hebert, J.R., Vatanparast, H., Kengne, A.P., The association between dietary inflammatory properties and bone mineral density and risk of fracture in US adults. Eur J Clin Nutr 71:11 (2017 Nov), 1273–1277, 10.1038/ejcn.2017.133 Epub 2017 Oct 11.
26. [accessed 19.08.13] http://www.cdc.gov/NCHS/data/nhanes/nhanes_09_10/CRP_F_met.pdf.
27. Mazidi, M, Michos, ED, Banach, M, The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the National Health and Nutrition Examination Survey. Arch. Med. Sci. 13:1 (2017 Feb 1), 61–65, 10.5114/aoms.2017.64714 Epub 2016 Dec 19.
28. National Center for Health Statistics CfDCaPNHaNESA, http://www.cdc.gov/nchs/nhanes.htmf.
29. Musso, G., Gambino, R., Bo, S., Uberti, B., Biroli, G., Pagano, G., et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 31:3 (2008), 562–568.
30. Simental-Mendia, L.E., Rodriguez-Moran, M., Guerrero-Romero, F., The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab. Syndrome Relat. Disord. 6:4 (2008), 299–304.
31. Samouda, H., Dutour, A., Chaumoitre, K., Panuel, M., Dutour, O., Dadoun, F., VAT=TAAT-SAAT: innovative anthropometric model to predict visceral adipose tissue without resort to CT-Scan or DXA. Obesity 21:1 (2013), E41–E50 (Silver Spring).
32. Liu, Y., The relationship between lifestyle and self-reported oral health among American adults. Int. Dent. J. 64:1 (2014), 46–51.
33. Chavers, B.M., Simonson, J., Michael, A.F., A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int. 25:3 (1984), 576–578.
34. Mazidi, M., Gao, H.K., Shivappa, N., Wirth, M.D., Hebert, J.R., Kengne, A.P., The relationship of plasma Trans fatty acids with dietary inflammatory index among US adults. Lipids Health Dis, 16(1), 2017 Aug 4, 147, 10.1186/s12944-017-0527-1.
35. VanderWeele, T.J., Mediation and mechanism. Eur. J. Epidemiol. 24:5 (2009), 217–224.
36. VanderWeele, T.J., A three-way decomposition of a total effect into direct, indirect, and interactive effects. Epidemiology 24:2 (2013), 224–232.
37. Preacher, K.J., Hayes, A.F., Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Meth. 40:3 (2008), 879–891.
38. MacKinnon, D.P., Fairchild, A.J., Fritz, M.S., Mediation analysis. Annu. Rev. Psychol. 58 (2007), 593–614.
39. Fang, J., Alderman, M.H., Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283:18 (2000), 2404–2410.
40. Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K.K., Ioannidis, J.P., et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ, 357, 2017, j2376.
41. Lyngdoh, T., Marques-Vidal, P., Paccaud, F., Preisig, M., Waeber, G., Bochud, M., et al. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One, 6(5), 2011, e19901.
42. Leyva, F., Anker, S.D., Godsland, I., Teixeira, M., Hellewell, P., Kox, W., et al. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur. Heart J. 19:12 (1998), 1814–1822.
43. Olexa, P., Olexová, M., Gonsorcík, J., Tkác, I., Kisel'ová, J., Olejníková, M., Uric acid–a marker for systemic inflammatory response in patients with congestive heart failure?. Wien Klin. Wochenschr. 114:5–6 (2002), 211–215.
44. Ruggiero, C., Cherubini, A., Miller, E., Maggio, M., Najjar, S.S., Lauretani, F., et al. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am. J. Cardiol. 100:1 (2007), 115–121.
45. Chang, C.-H., Chen, Y.-M., Chuang, Y.-W., Liao, S.-C., Lin, C.-S., Tang, Y.-J., et al. Relationship between hyperuricemia (HUC) and metabolic syndrome (MS) in institutionalized elderly men. Arch. Gerontol. Geriatr. 49 (2009), S46–S49.
46. Carvalho Vidigal, Fd, Frandsen Paez de Lima Rosado, L.E., Paixão Rosado, G., Ribeiro, C.L., Franceschini, C.C., Ácido úrico sérico puede predecir mayores niveles de proteína C-reactiva en hombres adultos sanos. Nutr. Hosp. 29:4 (2014), 935–940.
47. Raeisi, A., Ostovar, A., Vahdat, K., Rezaei, P., Darabi, H., Moshtaghi, D., et al. Association of serum uric acid with high-sensitivity C-reactive protein in postmenopausal women. Climacteric 20:1 (2017), 44–48.
48. Keenan, J.M., Pins, J.J., Frazel, C., Moran, A., Turnquist, L., Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. J. Fam. Pract., 51(4), 2002, 369.
49. Ford, E.S., Li, C., Cook, S., Choi, H.K., Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115:19 (2007), 2526–2532.
50. Gil-Campos, M., Aguilera, C.M., Canete, R., Gil, A., Uric acid is associated with features of insulin resistance syndrome in obese children at prepubertal stage. Nutr. Hosp. 24:5 (2009), 607–613.
51. Pirro, M., Mannarino, M.R., Bianconi, V., De Vuono, S., Sahebkar, A., Bagaglia, F., et al. Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat. Osteoporos. Int 28:3 (2017), 973–981 a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.
52. Chou, P., Lin, K.-C., Lin, H.-Y., Tsai, S.-T., Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. J. Rheumatol. 28:3 (2001), 571–576.
53. Nan, H., Pang, Z., Wang, S., Gao, W., Zhang, L., Ren, J., et al. Serum uric acid, plasma glucose and diabetes. Diabetes Vasc. Dis. Res. 7:1 (2010), 40–46.
54. Rathmann, W., Funkhouser, E., Dyer, A.R., Roseman, J.M., Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Ann. Epidemiol. 8:4 (1998), 250–261.
55. Kodama, S., Saito, K., Yachi, Y., Asumi, M., Sugawara, A., Totsuka, K., et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32:9 (2009), 1737–1742.
56. Sluijs, I., Beulens, J.W., Spijkerman, A.M., Schulze, M.B., van der Schouw, Y.T., Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. J. Nutr. 143:1 (2013), 80–85.
57. Qiu, Q., Gong, Y., Liu, X., Dou, L., Wang, Y., Wang, B., et al. Serum uric acid and impaired glucose tolerance: the Cardiometabolic Risk in Chinese (CRC) Study. Cell Biochem. Biophys. 73:1 (2015), 155–162.
58. Wang, Y., Chi, J., Che, K., Chen, Y., Sun, X., Wang, Y., et al. Fasting plasma glucose and serum uric acid levels in a general Chinese population with normal glucose tolerance: a U-shaped curve. PLoS One, 12(6), 2017, e0180111.
59. Dragan, S., Serban, M.C., Banach, M., Proprotein convertase subtilisin/kexin 9 inhibitors: an emerging lipid-lowering therapy?. J. Cardiovasc. Pharmacol. Therapeut. 20:2 (2015), 157–168.
60. Ruscica, M., Ferri, N., Fogacci, F., Rosticci, M., Botta, M., Marchiano, S., et al. Circulating levels of proprotein convertase subtilisin/kexin type 9 and arterial stiffness in a large population sample: data from the brisighella heart study. J. Am. Heart Assoc., 6(5), 2017.
61. Yoo, H.-G., Lee, S.-I., Chae, H.-J., Park, S.J., Lee, Y.C., Yoo, W.-H., Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis. Rheumatol. Int. 31:4 (2011), 485–491.
62. Feig, D.I., Kang, D.-H., Johnson, R.J., Uric acid and cardiovascular risk. N. Engl. J. Med. 359:17 (2008), 1811–1821.
63. Mazidi, M., Toth, P.P., Banach, M., C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults. Angiology, 2017 Jan 1, 3319717729288, 10.1177/0003319717729288 [Epub ahead of print] PMID: 28914081.